Stock Taper 
OPUS POINT PARTNERS MANAGEMENT, LLC
Latest 13F filing data - Q3 2019
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Vertex Pharmaceuticals Incorporated | VRTX | 8.28K | $1.4M |
 Ascendis Pharma A/S | ASND | 6.19K | $596K |
 Ultragenyx Pharmaceutical Inc. | RARE | 5.06K | $217K |
 Illumina, Inc. | ILMN | 4.72K | $1.44M |
 Gilead Sciences, Inc. | GILD | 4.08K | $259K |
 United Therapeutics Corporation | UTHR | 3.5K | $279K |
 Mettler-Toledo International Inc. | MTD | 3.23K | $2.28M |
 Neurocrine Biosciences, Inc. | NBIX | 3.13K | $282K |
 Regeneron Pharmaceuticals, Inc. | REGN | 2.44K | $677K |
 Ligand Pharmaceuticals Incorporated | LGND | 2.43K | $242K |
 Charles River Laboratories International, Inc. | CRL | 2.11K | $280K |
 IQVIA Holdings Inc. | IQV | 1.99K | $297K |
 Bio-Techne Corporation | TECH | 1.55K | $303K |
 Amgen Inc. | AMGN | 1.52K | $294K |
 Biogen Inc. | BIIB | 1.12K | $261K |